State Street Health Care Select Sector SPDR ETF XLV

El Fondo de Salud Health Care Select Sector SPDR Fund (el Fondo) busca igualar de cerca los rendimientos y características del Índice de Salud Health Care Select Sector de S&P (el Índice). Las empresas incluidas en el Índice son seleccionadas en base a la clasificación general de la industria de un universo de empresas definido por el Índice Compuesto de Acciones Standard & Poor's 500 (S&P 500). El Índice de Salud Health Care Select Sector incluye empresas de industrias como farmacéuticas, proveedores y servicios de atención médica, equipos y suministros médicos, biotecnología, herramientas y servicios de ciencias de la vida, y tecnología de la salud. Bajo condiciones normales de mercado, el Fondo generalmente invierte sustancialmente todos, pero al menos el 95%, de sus activos totales en los valores que componen el Índice. State Street Global Advisors actúa como el administrador de inversiones del Fondo.

Con 6 acciones de XLV (USD 1.002,21) habrías recibido USD 15,30 en dividendos en los últimos 12 meses.

• Zacks Investment Research 2 oct

  Stock Market News for Oct 2, 2026

  U.S. stock markets ended Thursday's volatile session in positive territory as Treasury yields retreated from 24-year highs, boosting investor sentiment. The Dow, Nasdaq, and S&P 500 all gained modestly. Micron Technology reported exceptional fourth-quarter earnings with non-GAAP EPS surging 11-fold year-over-year, driven by strong AI demand and tight memory conditions. Economic data showed manufacturing activity remained in expansion territory while jobless claims fell below expectations.

  

• The Motley Fool 13 sept

  State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors

  XLV and IXJ are two healthcare ETFs with different approaches: XLV focuses on 60 U.S. S&P 500 healthcare stocks with a low 0.08% expense ratio and stronger recent returns, while IXJ offers broader global diversification with 110 holdings across multiple countries but charges a higher 0.38% expense ratio. The choice depends on whether investors prioritize cost efficiency and domestic concentration or international diversification.

  

• Zacks Investment Research 8 sept

  Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?

  The ALPS Medical Breakthroughs ETF (SBIO) is a passively managed healthcare ETF that tracks small-cap and mid-cap pharmaceutical and biotechnology stocks in Phase II or Phase III FDA clinical trials. With a 0.5% expense ratio, $243.54 million in assets, and 107 holdings, it has delivered 32.1% year-to-date returns and 82.83% over 12 months. However, it carries high risk with a beta of 0.74 and 30.54% standard deviation. The fund received a Zacks ETF Rank of 3 (Hold), with alternatives like VHT and XLV offering lower expense ratios.

  

• Zacks Investment Research 31 ago

  Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

  RSPH, an equal-weight healthcare ETF launched in 2006, has gained 17.92% year-to-date and 29.15% over the past year as of August 31, 2026. With $826.52 million in assets and a 0.40% expense ratio, it offers diversified exposure to 63 healthcare holdings. However, cheaper alternatives like VHT (0.09% expense ratio) and XLV (0.08% expense ratio) may be more suitable for cost-conscious investors seeking lower-risk options.

  

• The Motley Fool 8 ago

  Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?

  The article compares two healthcare sector ETFs: Vanguard Health Care ETF (VHT) with 423 holdings and State Street Health Care Select Sector SPDR ETF (XLV) with 60 holdings. While XLV has slightly lower expenses (0.08% vs 0.09%) and better 5-year returns, VHT outperforms on 1-year returns and offers broader diversification. The analysis recommends VHT for long-term investors due to superior recent performance and lower concentration risk.